Dr. Katey Owen has served on Adaptive Biotechnologies' board of directors since March 2021. She joined the Bill & Melinda Gates Foundation in 2013 as Deputy Director of Vaccine Development, became Director, Neglected Tropical Diseases in 2017 and Director, Vaccine Development in November 2022, with responsibility for large vaccine and neglected-tropical-disease portfolios and the Foundation's pharmaceutical-industry engagement. Before the Gates Foundation she held roles of increasing responsibility at Merck & Co., including in Merck Vaccines, Merck Manufacturing Division and Merck Research Laboratories. She serves on the board of the Coalition for Epidemic Preparedness Innovations and as a board observer for other health organizations. Dr. Owen holds a PhD in Molecular Virology and a BS in Genetic Biology from Purdue University.